Phocas Financial’s Diplomat Pharmacy DPLO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
– Sell
-200,649
Closed -$3.9M – 366
2018
Q3
$3.9M Sell
200,649
-3,641
-2% -$77.5K 0.34% 115
2018
Q2
$5.22M Sell
204,290
-423,709
-67% -$9.9M 0.45% 102
2018
Q1
$12.7M Sell
627,999
-35,188
-5% -$821K 1.14% 25
2017
Q4
$13.3M Buy
663,187
+390,168
+143% +$7.67M 1.12% 23
2017
Q3
$6M Buy
+273,019
New +$4.62M 0.5% 90

Other funds holding DPLO

Phocas Financial's DPLO Position: Q4 2018 in Review

Phocas Financial sold out of Diplomat Pharmacy (DPLO) in Q4 2018, closing a stake of 200,649 shares — an estimated $3.9M sold.

Phocas Financial first reported a position in DPLO in Q3 2017 and held it in 5 quarters. The position peaked at $13.3M in Q4 2017. 157 funds tracked by Wall St. Rank hold DPLO as of Q4 2018.

  • Phocas Financial reported no remaining Diplomat Pharmacy position as of Q4 2018 after selling out during the quarter.
  • Phocas Financial sold 200,649 Diplomat Pharmacy shares in Q4 2018, an estimated $3.9M.
  • Phocas Financial first reported a position in Diplomat Pharmacy in Q3 2017 and held it in 5 quarters.
  • Phocas Financial's Diplomat Pharmacy position peaked at $13.3M in Q4 2017.
  • 157 funds tracked by Wall St. Rank held Diplomat Pharmacy as of Q4 2018.

Based on Phocas Financial's 13F filing for Q4 2018, filed 15 Feb 2019.